8MW-2311
- Generic Name
- 8MW-2311
A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors
- First Posted Date
- 2022-06-13
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Target Recruit Count
- 216
- Registration Number
- NCT05416749
- Locations
- 🇨🇳
The first affiliated hospital of bengbu medicial college, Bengbu, Anhui, China
🇨🇳Hunan cancer hospital, Changsha, Hunan, China
🇨🇳Jian Zhang, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath